Immunome Growth Metrics (2023-2025) | IMNM

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) 564.58%614.89%175.76%61.73%7.17%0.03%16.54%
Assets (QoQ) -13.88%124.84%59.44%115.26%-7.36%-13.27%-6.48%42.65%-13.54%1.04%
Capital Expenditures Growth (1y) 870.40%951.12%4,175.00%222.64%69.36%-61.39%-27.49%
Capital Expenditures (QoQ) 0.00%-83.86%869.44%520.06%8.32%-34.34%-26.84%225.49%-75.31%23.31%
Cash & Equivalents Growth (1y) 507.16%330.37%71.63%45.27%-4.49%-12.96%75.25%
Cash & Equivalents (QoQ) -13.52%135.95%8.87%173.33%-38.70%-5.91%-7.85%79.71%-44.14%89.46%
Cash from Investing Activities Growth (1y) -35,023.58%-23,925.88%67,038.89%132.52%113.67%21.44%414.08%
Cash from Investing Activities (QoQ) -220.75%89.41%-83,238.89%-24.10%-119.41%129.50%-59.51%-47.85%-1,360.97%293.05%
Cash from Operations Growth (1y) -146.21%-312.79%-296.64%-140.91%-374.98%-111.14%-18.56%
Cash from Operations (QoQ) -123.45%-51.98%-102.68%36.02%-109.46%-46.03%-23.10%-26.14%6.89%18.00%
EBITDA Margin Growth (1y) -1.27M-0.16M-0.16M-0.06M1.13M0.05M
EBITDA Margin (QoQ) 0.01M546.00-0.23M-1.04M1.12M-0.00M-0.13M0.15M0.04M
EBIT Growth (1y) -2,859.05%-593.04%-990.48%12.34%66.26%-16.17%-19.03%
EBIT Margin Growth (1y) -1.27M-0.16M-0.16M-0.06M1.13M0.05M
EBIT Margin (QoQ) 0.01M546.00-0.23M-1.04M1.12M-0.00M-0.13M0.15M0.04M
EBIT (QoQ) -29.12%19.75%-1,943.02%-39.77%69.76%-26.28%-64.23%46.20%-4.13%-29.39%
EBT Growth (1y) -2,859.05%-593.04%-990.48%12.34%66.26%-16.17%-19.03%
EBT Margin Growth (1y) -1.27M-0.16M-0.16M-0.06M1.13M0.05M
EBT Margin (QoQ) 0.01M546.00-0.23M-1.04M1.12M-0.00M-0.13M0.15M0.04M
EBT (QoQ) -29.12%19.75%-1,943.02%-39.77%69.76%-26.28%-64.23%46.20%-4.13%-29.39%
Enterprise Value Growth (1y) 6,939.36%668.44%5,569.57%39.65%-76.98%20.98%17.06%
Enterprise Value (QoQ) 252.14%-80.67%2,736.15%264.67%-61.56%42.60%-30.14%-39.88%102.02%37.99%
EPS (Basic) Growth (1y) -617.14%-30.43%-116.67%69.67%79.28%16.67%16.67%
EPS (Basic) (QoQ) -31.43%21.74%-1,072.22%40.52%76.10%-30.00%-64.10%59.38%3.85%-30.00%
EPS (Weighted Average and Diluted) Growth (1y) -617.14%-30.43%-116.67%69.67%79.28%16.67%16.67%
EPS (Weighted Average and Diluted) (QoQ) -31.43%21.74%-1,072.22%40.52%76.10%-30.00%-64.10%59.38%3.85%-30.00%
FCF Margin Growth (1y) -0.23M-0.10M-0.10M-0.11M-0.06M-0.02M
FCF Margin (QoQ) -0.12M-0.01M-0.02M-0.08M0.02M-0.01M-0.04M-0.04M0.07M
Free Cash Flow Growth (1y) -155.67%-336.95%-312.79%-142.51%-325.38%-95.43%-16.58%
Free Cash Flow (QoQ) -124.60%-46.83%-105.87%25.12%-93.05%-38.71%-20.95%-31.34%11.31%17.25%
Net Cash Flow Growth (1y) 609.70%-1,637.53%-118.70%-251.99%-33.20%-8.85%1,418.75%
Net Cash Flow (QoQ) -124.93%969.26%-84.61%2,027.94%-161.03%90.65%-25.12%1,035.27%-199.44%213.32%
Net Income Growth (1y) -2,859.05%-593.04%-990.48%12.34%66.26%-16.17%-19.03%
Net Income (QoQ) -29.12%19.75%-1,943.02%-39.77%69.76%-26.28%-64.23%46.20%-4.13%-29.39%
Net Income towards Common Stockholders Growth (1y) -2,859.05%-593.04%-1,062.76%10.43%66.26%-16.17%-19.03%
Net Income towards Common Stockholders (QoQ) -29.12%24.74%-2,031.97%-42.82%69.76%-26.28%-64.23%46.20%-4.13%-29.39%
Net Margin Growth (1y) -1.27M-0.16M-0.16M-0.06M1.13M0.05M
Net Margin (QoQ) 0.01M0.00M-0.23M-1.04M1.12M-0.00M-0.13M0.15M0.04M
Operating Income Growth (1y) -2,859.05%-593.04%-990.48%12.34%66.26%-16.17%-19.03%
Operating Income (QoQ) -29.12%19.75%-1,943.02%-39.77%69.76%-26.28%-64.23%46.20%-4.13%-29.39%
Operating Margin Growth (1y) -1.27M-0.16M-0.16M-0.06M1.13M0.05M
Operating Margin (QoQ) 0.01M546.00-0.23M-1.04M1.12M-0.00M-0.13M0.15M0.04M
Profit After Tax Growth (1y) -2,932.60%-550.03%-984.00%13.37%67.84%-20.14%-21.99%
Profit After Tax (QoQ) -30.14%21.81%-2,031.97%-39.79%72.10%-30.39%-70.38%48.11%-4.22%-32.40%
Property, Plant & Equipment (Net) Growth (1y) 369.65%406.73%511.95%387.84%154.60%80.86%61.22%
Property, Plant & Equipment (Net) (QoQ) 31.33%-2.58%76.88%107.53%41.70%17.65%41.01%8.31%0.66%4.88%
Return on Assets Growth (1y) -32.0027.0018.0036.00
Return on Assets (QoQ) -11.0013.00-27.00-8.0048.005.00-8.00
Return on Capital Employed Growth (1y) -47.0033.0026.0046.00
Return on Capital Employed (QoQ) -6.0015.00-33.00-23.0074.008.00-12.00
Return on Equity Growth (1y) 19.0028.0023.0048.00
Return on Equity (QoQ) 57.0016.00-35.00-19.0065.0011.00-10.00
Return on Sales Growth (1y) -0.00M-123.00734.00
Return on Sales (QoQ) -0.00M-647.00-616.00-248.000.00M210.00
Revenue Growth (1y) -56.47%-44.55%-18.37%-28.44%184.35%69.84%
Revenue (QoQ) 80.33%-16.37%7.32%-73.11%129.74%23.10%-5.91%6.87%37.22%
Share-based Compensation Growth (1y) 76.39%212.39%351.71%89.73%164.15%65.70%37.92%
Share-based Compensation (QoQ) -15.60%4.84%166.20%-25.11%49.47%51.60%11.82%4.26%-6.24%26.18%
Shareholder's Equity Growth (1y) 1,960.11%2,618.33%3,436.97%51.12%7.55%6.08%22.81%
Shareholder's Equity (QoQ) -32.64%-34.93%1,873.04%138.21%-11.11%-15.34%-15.70%69.53%-12.33%-1.99%